$12.24
1.83% yesterday
Nasdaq, Dec 24, 08:12 pm CET
ISIN
US92556V1061
Symbol
VTRS

Viatris Stock price

$12.24
+1.67 15.80% 1M
+3.29 36.76% 6M
-0.21 1.69% YTD
-0.16 1.29% 1Y
+1.23 11.17% 3Y
-5.53 31.12% 5Y
-42.58 77.67% 10Y
-8.06 39.70% 20Y
Nasdaq, Closing price Wed, Dec 24 2025
+0.22 1.83%

New AI Insights on Viatris Insights AI Insights on Viatris

How does the company make money?
Who are the company’s main competitors?
What are the key opportunities and risks?
How is the company managed?

Key metrics

Basic
Market capitalization
-
Enterprise Value
-
Net debt
$13.4b
Cash
$1.1b
Shares outstanding
1.2b
Valuation (TTM | estimate)
P/E
negative | 5.2
P/S
- | -
EV/Sales
- | -
EV/FCF
-
P/B
-
Dividends
DPS
$0.48
Yield 1Y | 5Y
3.9% | 3.9%
Growth 1Y | 5Y
0.0% | -
Payout 1Y | 3Y
-90.6% | 117.1%
Increased
0 Years
Financials (TTM | estimate)
Revenue
$14.1b | $14.4b
EBITDA
$4.1b | $4.2b
EBIT
$1.3b | $3.8b
Net Income
$-3.7b | $2.7b
Free Cash Flow
$1.6b
Growth (TTM | estimate)
Revenue
-6.1% | -2.2%
EBITDA
-1.1% | -10.2%
EBIT
-2.5% | 115.6%
Net Income
-317.9% | 532.0%
Free Cash Flow
-14.9%
Margin (TTM | estimate)
Gross
39.4%
EBITDA
29.0% | 29.1%
EBIT
9.3%
Net
-26.1% | 19.0%
Free Cash Flow
11.4%
Financial Health
Equity Ratio
44.9%
Return on Equity
-3.4%
ROCE
4.3%
ROIC
3.7%
Debt/Equity
0.9
More
EPS
$-3.2
FCF per Share
$1.4
Short interest
2.6%
Employees
32k
Rev per Employee
$460.0k
Show more

Is Viatris a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,079 stocks worldwide.

Viatris Stock Analysis

Unlock Scores for Free

Analyst Opinions

17 Analysts have issued a Viatris forecast:

9x Buy
53%
6x Hold
35%
2x Sell
12%

Analyst Opinions

17 Analysts have issued a Viatris forecast:

Buy
53%
Hold
35%
Sell
12%

Financial data from Viatris

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
14,124 14,124
6% 6%
100%
- Direct Costs 8,565 8,565
1% 1%
61%
5,560 5,560
13% 13%
39%
- Selling and Administrative Expenses 3,356 3,356
21% 21%
24%
- Research and Development Expense 885 885
10% 10%
6%
4,096 4,096
1% 1%
29%
- Depreciation and Amortization 2,778 2,778
0% 0%
20%
EBIT (Operating Income) EBIT 1,319 1,319
2% 2%
9%
Net Profit -3,691 -3,691
318% 318%
-26%

In millions USD.

Don't miss a Thing! We will send you all news about Viatris directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Viatris Stock News

Neutral
PRNewsWire
7 days ago
Receives U.S. Food and Drug Administration (FDA) Approval for Generic Version of Sandostatin® LAR Depot (Octreotide Acetate for Injectable Suspension) U.S. FDA Accepts New Drug Application for Low Dose Estrogen Weekly Patch for Contraception U.S. FDA Clears Investigational New Drug Application for MR-146 in Neurotrophic Keratopathy Japan Pharmaceuticals and Medical Devices Agency Accepts Japane...
Neutral
PRNewsWire
8 days ago
PITTSBURGH , Dec. 17, 2025 /PRNewswire/ -- Viatris Inc. (Nasdaq: VTRS), a global healthcare company, today announced that the Company will present at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco on Tuesday, Jan. 13, 2026.
Neutral
PRNewsWire
19 days ago
Viatris to Receive $400 Million in Cash and $415 Million in Equity Shares of Biocon Limited Transaction Accelerates the Expiration of Biosimilars Non-Compete Restrictions PITTSBURGH , Dec. 6, 2025 /PRNewswire/ -- Viatris Inc.  (Nasdaq: VTRS) today announced that it has entered into definitive agreements with Biocon Limited ("Biocon") for the sale of Viatris' equity stake in Biocon Biologics Lim...
More Viatris News

Company Profile

Viatris, Inc. engages in the commercialization and manufacturing of pharmaceutical products. It also offers support services such as diagnostic clinics, educational seminars, and digital tools. The company was founded on February 14, 2019 and is headquartered in Canonsburg, PA.

Head office United States
CEO Scott Smith
Employees 32,000
Founded 2019
Website www.viatris.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today